Table 1

Differences between COVID-19 patients with or without CVD

VariableWithout CVD (n=397)
n (%)
With CVD (n=144)
n (%)
P value
Male183 (46.1)72 (50.0)0.437
Age
Mean (SD)53.25±16.2969.66±10.94<0.001
≤40105 (26.4)0 (0)
40–60138 (34.8)30 (20.8)
60–80138 (34.8)90 (62.5)
>8016 (4.0)24 (16.7)
Fever316 (79.6)118 (81.9)0.626
Fatigue125 (31.5)53 (36.8)0.256
Cough244 (61.5)93 (64.6)0.548
Sputum production93 (23.4)48 (33.3)0.026
Chest congestion91 (22.9)39 (27.1)0.362
Dizziness13 (3.3)6 (4.2)0.603
Headache13 (3.3)6 (4.2)0.603
Dyspnoea89 (22.4)41 (28.5)0.172
Disturbance of consciousness5 (1.3)4 (2.8)0.256
Arthralgia40 (10.1)13 (9.0)0.870
Stomach-ache2 (0.5)3 (2.1)0.120
Diarrhoea45 (11.3)18 (12.5)0.762
Nausea15 (3.8)11 (7.6)0.071
Emesis7 (1.8)6 (4.2)0.118
Leucocytes <3.5×10⁹/L41 (10.3)13 (9.0)0.747
Leucocytes >9.5×10⁹/L36 (9.1)32 (22.2)<0.001
Lymphocytes <1.1×10⁹/L203 (51.1)93 (64.6)0.006
Haemoglobin <115.0 g/L122 (30.7)71 (49.3)<0.001
Albumin <40.0 g/L277 (69.8)120 (83.3)0.001
C reactive protein >10.0 mg/L265 (66.8)121 (84.0)<0.001
Aspartate aminotransferase >35.0 U/L99 (24.9)50 (34.7)0.029
Alanine aminotransferase >40.0 U/L93 (23.4)41 (28.5)0.260
Serum creatinine >81.0 μmol/L37 (9.3)27 (18.8)0.004
Lactate dehydrogenase >250.0 U/L190 (47.9)93 (64.6)0.001
Disease grade
 Ordinary154 (38.8)28 (19.4)
 Severe208 (52.4)76 (52.8)
 Critical35 (8.8)40 (27.8)<0.001
 Death21 (5.3)32 (22.2)<0.001
 Recovered119 (30.0)35 (24 .3)0.197
  • CVD, cardiovascular disease.